Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Fitzgerald reports grants from Boehringer Ingelheim, during the conduct of the study; personal fees and grants from Boehringer Ingelheim, AstraZeneca, Novartis, Sanofi-Regeneron, Circassia and Teva; and grants from GlaxoSmithKline, outside the submitted work.
Conflict of interest: Dr. Buhl reports grants to Mainz University and personal fees from Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Roche, as well as personal fees from AstraZeneca, Chiesi, Cipla and Teva, outside the submitted work.
Conflict of interest: Dr. Casale reports other from AstraZeneca, Sanofi/Roche and Novartis, personal fees and other from Genentech, and grants from AstraZeneca, Sanofi/Roche, Genentech and Novartis, outside the submitted work.
Conflict of interest: Dr. Jugovic is an employee of Boehringer Ingelheim.
Conflict of interest: Dr. Zaremba-Pechmann has nothing to disclose.
Conflict of interest: Dr. Halpin reports personal fees from AstraZeneca, Chiesi and Pfizer, and grants and personal fees from Boehringer Ingelheim, GlaxoSmithKline and Novartis, outside the submitted work.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received May 13, 2019.
- Accepted September 14, 2019.
- Copyright ©ERS 2019